DIRAS2 and colorectal cancer: PSMD2 also reduces the protein levels of a variety of Ras-related GTPase, including DIRAS family GTPase 2 (DIRAS2) through the proteasome-mediated pathway and subsequently blocks the NF-κB signalling pathway and suppresses cell proliferation in colorectal cancer [60].